STERIS plc Stock
STERIS plc Stock
Our community is currently high on STERIS plc with 4 Buy predictions and 0 Sell predictions.
Pros and Cons of STERIS plc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of STERIS plc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
STERIS plc | - | - | - | - | - | - | - |
Smith & Nephew plc | -0.530% | -1.514% | -8.040% | -16.722% | -8.887% | -32.782% | - |
Dexcom Inc. | -3.610% | -3.043% | 1.791% | 16.341% | 12.683% | 51.180% | 413.106% |
Baxter International | 0.120% | -5.083% | -2.614% | -4.609% | 6.277% | -48.004% | -43.025% |
Comments
STERIS plc (NYSE: STE) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $250.00 price target on the stock.
Show more
Ratings data for STE provided by MarketBeat
STERIS plc (NYSE: STE) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $253.00 price target on the stock.
Show more
Ratings data for STE provided by MarketBeat
STERIS plc (NYSE: STE) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $250.00 price target on the stock.
Show more
Ratings data for STE provided by MarketBeat